Cargando…
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
Hepatocellular carcinoma (HCC) is an aggressive primary liver neoplasm that, according to tumor stage, can be treated with resection, transplantation, locoregional treatment options, or systemic therapy. Although interventions only in early-stage disease can offer complete tumor regression, systemic...
Autores principales: | Ouranos, Konstantinos, Chatziioannou, Anthi, Goulis, Ioannis, Sinakos, Emmanouil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693898/ https://www.ncbi.nlm.nih.gov/pubmed/36437845 http://dx.doi.org/10.5500/wjt.v12.i11.331 |
Ejemplares similares
-
The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence
por: Sinakos, Emmanouil, et al.
Publicado: (2011) -
Impact and management of COVID-19 in liver transplant candidates and recipients
por: Liava, Christina, et al.
Publicado: (2023) -
Liver Imaging Reporting and Data System criteria for the diagnosis of hepatocellular carcinoma in clinical practice: A pictorial minireview
por: Liava, Christina, et al.
Publicado: (2022) -
Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma
por: Woo, Stephanie M., et al.
Publicado: (2022) -
Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?
por: Papagiouvanni, Ioanna, et al.
Publicado: (2022)